Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-106880
Filing Date
2024-09-16
Accepted
2024-09-16 16:41:51
Documents
1
Period of Report
2024-09-12

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4567
  Complete submission text file 0000950170-24-106880.txt   5990
Mailing Address C/O JANUX THERAPEUTICS, INC. 11099 N. TORREY PINES ROAD, SUITE 290 LA JOLLA CA 92037
Business Address
Simson Jake (Reporting) CIK: 0001863094 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42271 | Film No.: 241301623

Mailing Address 245 MAIN STREET CAMBRIDGE MA 02142
Business Address 245 MAIN STREET CAMBRIDGE MA 02142 617-785-8308
Bicara Therapeutics Inc. (Issuer) CIK: 0002023658 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)